Details
ViiV Healthcare is a global specialty pharmaceutical company focused exclusively on research, development, and delivery of treatments for HIV. It was established as a joint venture between GSK, Pfizer, and Shionogi, and is headquartered in the United Kingdom.
The company develops innovative antiretroviral therapies aimed at improving the lives of people living with HIV. Its portfolio includes long-acting injectable treatments, combination therapies, and other advanced solutions designed to simplify treatment regimens and support better long-term health outcomes. ViiV Healthcare is also actively involved in research aimed at advancing toward HIV prevention and potential functional cures.
ViiV Healthcare operates with a strong patient-centered mission, prioritizing accessibility, innovation, and reducing the global impact of HIV. Employees work in a highly specialized and research-driven environment across areas such as clinical development, medical affairs, regulatory, manufacturing, and commercial functions. The company culture emphasizes collaboration, scientific excellence, and social impact.